RareWays is a research directory. It helps you understand the science. It is not medical advice. Always discuss your care options with your healthcare team.
Coverage: 2020-01-01 onwards, with up to 300 results per query from PubMed and Europe PMC and separate limits on other sources. This is a selected index, not a complete literature search.
Updates are delayed or unverified. Check original sources for the latest information.
Your saved research and appointment questionsView recorded trial and retraction changes
MALT Lymphoma: Research Summary
Printed from RareWays (rareways.org)
For general awareness only. Not medical advice. Discuss all care options with your healthcare team.
5 Most Recent Research Articles
- 1.
[Case #1. Pulmonary MALT lymphoma: A diagnosis not to be missed in the presence of a slowly progressive lung lesion].
Damotte Diane, Annales de pathologie (12 October 2026)
https://pubmed.ncbi.nlm.nih.gov/42864223/
- 2.
Extranodal marginal zone lymphoma: epidemiological, clinical features and treatment outcomes
Manel Rebah et al., Pan African Medical Journal (7 October 2026)
https://doi.org/10.11604/pamj.2026.55.65.49140
- 3.
Extranodal Marginal Zone Lymphoma of the Floor of the Mouth: A Rare Entity With Management Challenges
Nourelhouda Mouhib et al., Cureus (5 October 2026)
https://doi.org/10.7759/cureus.117490
- 4.
Pitfall in Routine Gastroscopy: HP-Negative Tiny Pale Depressed Gastric Fundus MALT Lymphoma Easily Missed by Naked Eye.
Tang Zhen et al., Digestive diseases and sciences (1 October 2026)
https://pubmed.ncbi.nlm.nih.gov/42251236/
- 5.
Comment on: Clinicopathological and Imaging Distinction Between Ocular Adnexal MALT Lymphoma and IgG4-Related Ophthalmic Disease.
Panda Bijnya Birajita, American journal of ophthalmology (1 October 2026)
https://pubmed.ncbi.nlm.nih.gov/42362133/
Clinical Trials : Australian Sites
Ask your doctor whether you or your child may be eligible for any of these trials. Each has its ID and full eligibility criteria at the link shown.
- 1.
PSB202 in Patients With Previously Treated-, Relapsed-, Indolent B-Cell Malignancies
NCT05003141 · UNKNOWN · Phase 1 · Qilu Puget Sound Biotherapeutics (dba Sound Biologics)
Ages 18 and over
https://clinicaltrials.gov/study/NCT05003141
Source: RareWays research directory. Data from PubMed, Europe PMC, OpenAlex, ClinicalTrials.gov.
Always verify information with your healthcare team before making any decisions about your care.
MALT Lymphoma
MALT lymphoma is a rare, usually slow-growing cancer of B cells, a type of white blood cell, that arises in mucosal tissue outside the lymph nodes. It most often affects the stomach but can also involve the lungs, eyes, salivary glands, thyroid or skin. It is often linked to long-term infection or inflammation. Treatment depends on the site and stage and may include antibiotics, radiotherapy, immunotherapy or chemotherapy.
This overview is general information, not an individual medical assessment. Research is selected automatically and may include mismatches. How we select and explain research.
Most Recent Research
Common Questions
What is MALT Lymphoma?
MALT lymphoma is a rare, usually slow-growing cancer of B cells, a type of white blood cell, that arises in mucosal tissue outside the lymph nodes. It most often affects the stomach but can also involve the lungs, eyes, salivary glands, thyroid or skin. It is often linked to long-term infection or inflammation. Treatment depends on the site and stage and may include antibiotics, radiotherapy, immunotherapy or chemotherapy.
How many clinical trials are available for MALT Lymphoma?
RareWays currently indexes 155 clinical trials for MALT Lymphoma, of which 9 are actively recruiting. These counts cover indexed trials across countries, not just your country. An Australian site does not necessarily mean that site is recruiting. Check locations, eligibility and current availability with the study team.
Where does the research data for MALT Lymphoma come from?
RareWays aggregates research from PubMed, Europe PMC, OpenAlex, and ClinicalTrials.gov. Data is refreshed automatically every day. All articles and trials link directly to their original sources.
Get research updates
Monthly email when new findings are published for MALT Lymphoma.
Your email and selected disease are stored for these updates. Unsubscribe any time. Privacy and deletion.
This information is for general awareness only.
For guidance specific to your situation, please speak with your healthcare team.